Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(26)
- Computing and Computational Sciences Directorate (38)
- Energy Science and Technology Directorate
(223)
- Fusion and Fission Energy and Science Directorate (24)
- Information Technology Services Directorate (3)
- Isotope Science and Enrichment Directorate (7)
- National Security Sciences Directorate (20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (135)
- User Facilities (27)
Researcher
- Isabelle Snyder
- Adam Siekmann
- Andrzej Nycz
- Chris Masuo
- Emilio Piesciorovsky
- Luke Meyer
- Subho Mukherjee
- Vivek Sujan
- William Carter
- Aaron Werth
- Aaron Wilson
- Alex Walters
- Ali Riza Ekti
- Brian Sanders
- Bruce Hannan
- Elizabeth Piersall
- Eve Tsybina
- Gary Hahn
- Jerry Parks
- Joshua Vaughan
- Loren L Funk
- Nils Stenvig
- Ozgur Alaca
- Peter Wang
- Polad Shikhaliev
- Raymond Borges Hink
- Theodore Visscher
- Viswadeep Lebakula
- Vladislav N Sedov
- Yacouba Diawara
- Yarom Polsky

ORNL has developed a large area thermal neutron detector based on 6LiF/ZnS(Ag) scintillator coupled with wavelength shifting fibers. The detector uses resistive charge divider-based position encoding.

Faults in the power grid cause many problems that can result in catastrophic failures. Real-time fault detection in the power grid system is crucial to sustain the power systems' reliability, stability, and quality.

Water heaters and heating, ventilation, and air conditioning (HVAC) systems collectively consume about 58% of home energy use.

This disclosure introduces an innovative tool that capitalizes on historical data concerning the carbon intensity of the grid, distinct to each electric zone.

This disclosure introduces an innovative tool that capitalizes on historical data concerning the carbon intensity of the grid, distinct to each electric zone.

Electrical utility substations are wired with intelligent electronic devices (IEDs), such as protective relays, power meters, and communication switches.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).